Literature DB >> 22954608

Thrombocytopenia at diagnosis as an important negative prognostic marker in isolated 5q- MDS (IPSS low and intermediate-1).

Anna Jonasova, Jaroslav Cermak, Jana Vondrakova, Magda Siskova, Ivana Hochova, Eva Kadlckova, Olga Cerna, Michal Sykora, Vera Vozobulova, Nadezda Seifertova, Kyra Michalova, Zuzana Zemanova, Jana Brezinova, Petra Belohlavkova, Arnost Kostecka, Radana Neuwirtova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22954608     DOI： 10.1016/j.leukres.2012.08.002

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  1 in total

1.  TP53 mutation variant allele frequency is a potential predictor for clinical outcome of patients with lower-risk myelodysplastic syndromes.

Authors:  Monika Belickova; Jitka Vesela; Anna Jonasova; Barbora Pejsova; Hana Votavova; Michaela Dostalova Merkerova; Zuzana Zemanova; Jana Brezinova; Dana Mikulenkova; Marie Lauermannova; Jan Valka; Kyra Michalova; Radana Neuwirtova; Jaroslav Cermak
Journal:  Oncotarget       Date:  2016-06-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.